| Dr Melissa Peskin-stolze, MD | |
|
140 Bellemeade Rd, Suite E, East Setauket, NY 11733-6400 | |
| (631) 444-4686 | |
| (631) 444-4622 |
| Full Name | Dr Melissa Peskin-stolze |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 140 Bellemeade Rd, East Setauket, New York |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346512761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 264472 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
As American medical students increasingly want and expect to have international work experience, more and more short-term programs are being offered to give them that opportunity, according to Melissa Melby, assistant professor of anthropology at the University of Delaware.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
› Verified 9 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
As American medical students increasingly want and expect to have international work experience, more and more short-term programs are being offered to give them that opportunity, according to Melissa Melby, assistant professor of anthropology at the University of Delaware.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
As American medical students increasingly want and expect to have international work experience, more and more short-term programs are being offered to give them that opportunity, according to Melissa Melby, assistant professor of anthropology at the University of Delaware.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
As American medical students increasingly want and expect to have international work experience, more and more short-term programs are being offered to give them that opportunity, according to Melissa Melby, assistant professor of anthropology at the University of Delaware.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Peskin-stolze, MD Po Box 1554, Stony Brook, NY 11790-0988 Ph: (631) 444-0650 | Dr Melissa Peskin-stolze, MD 140 Bellemeade Rd, Suite E, East Setauket, NY 11733-6400 Ph: (631) 444-4686 |
News Archive
As American medical students increasingly want and expect to have international work experience, more and more short-term programs are being offered to give them that opportunity, according to Melissa Melby, assistant professor of anthropology at the University of Delaware.
Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today the Canadian approval for the company's KXL II System. The KXL II System performs a procedure called PiXL (Photorefractive Intrastromal Cross-Linking) which has the potential to deliver non-surgical correction of myopia, and improve cataract surgery outcomes.
PROLOR Biotech, Inc.,, a company developing next generation biobetter therapeutic proteins, today announced that the Tel Aviv Stock Exchange (TASE) has approved the new listing of PROLOR's common stock on the TASE beginning on Thursday, May 27, 2010. At that time, the company's common stock will be listed on both the NYSE Amex in the United States and the TASE in Israel.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.
University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".
› Verified 9 days ago
James Bernasko, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4 Technology Dr, Stony Brook University Physicians, East Setauket, NY 11733 Phone: 631-444-4686 | |
Dr. Todd R Griffin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6 Technology Dr, East Setauket, NY 11733 Phone: 631-444-4686 | |
Dr. Melissa Strafford, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4 Technology Dr, East Setauket, NY 11733 Phone: 631-444-4686 | |
Dr. Cecilia Avila, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6 Technology Dr, East Setauket, NY 11733 Phone: 631-444-4686 | |
Philip Schoenfeld, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 S Jersey Ave Unit 16, East Setauket, NY 11733 Phone: 631-689-6400 | |
David John Garry, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6 Technology Dr, East Setauket, East Setauket, NY 11733 Phone: 631-444-4686 Fax: 631-444-4622 | |
Dr. Jennifer Marie Blaber, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 N Belle Mead Ave, East Setauket, NY 11733 Phone: 631-444-4686 |